Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
van der Steen W, van de Graaf RA, Chalos V, Lingsma HF, van Doormaal PJ, Coutinho JM, Emmer BJ, de Ridder I, van Zwam W, van der Worp HB, van der Schaaf I, Gons RAR, Yo LSF, Boiten J, van den Wijngaard I, Hofmeijer J, Martens J, Schonewille W, Vos JA, Tuladhar AM, de Laat KF, van Hasselt B, Remmers M, Vos D, Rozeman A, Elgersma O, Uyttenboogaart M, Bokkers RPH, van Tuijl J, Boukrab I, van den Berg R, Beenen LFM, Roosendaal SD, Postma AA, Krietemeijer M, Lycklama G, Meijer FJA, Hammer S, van der Hoorn A, Yoo AJ, Gerrits D, Truijman MTB, Zinkstok S, Koudstaal PJ, Manschot S, Kerkhoff H, Nieboer D, Berkhemer O, Wolff L, van der Sluijs PM, van Voorst H, Tolhuisen M, Roos YBWEM, Majoie CBLM, Staals J, van Oostenbrugge RJ, Jenniskens SFM, van Dijk LC, den Hertog HM, van Es ACGM, van der Lugt A, Dippel DWJ, Roozenbeek B; MR CLEAN-MED investigators. van der Steen W, et al. Among authors: roozenbeek b. Lancet. 2022 Mar 12;399(10329):1059-1069. doi: 10.1016/S0140-6736(22)00014-9. Epub 2022 Feb 28. Lancet. 2022. PMID: 35240044 Clinical Trial.
Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) study.
Lingsma HF, Roozenbeek B, Li B, Lu J, Weir J, Butcher I, Marmarou A, Murray GD, Maas AI, Steyerberg EW. Lingsma HF, et al. Among authors: roozenbeek b. Neurosurgery. 2011 Mar;68(3):601-7; discussion 607-8. doi: 10.1227/NEU.0b013e318209333b. Neurosurgery. 2011. PMID: 21311293
The added value of ordinal analysis in clinical trials: an example in traumatic brain injury.
Roozenbeek B, Lingsma HF, Perel P, Edwards P, Roberts I, Murray GD, Maas AI, Steyerberg EW; IMPACT (International Mission on Prognosis and Clinical Trial Design in Traumatic Brain Injury) Study Group; CRASH (Corticosteroid Randomisation After Significant Head Injury) Trial Collaborators. Roozenbeek B, et al. Crit Care. 2011;15(3):R127. doi: 10.1186/cc10240. Epub 2011 May 17. Crit Care. 2011. PMID: 21586148 Free PMC article. Clinical Trial.
Prognostic value of major extracranial injury in traumatic brain injury: an individual patient data meta-analysis in 39,274 patients.
van Leeuwen N, Lingsma HF, Perel P, Lecky F, Roozenbeek B, Lu J, Shakur H, Weir J, Steyerberg EW, Maas AI; International Mission on Prognosis and Clinical Trial Design in TBI Study Group; Corticosteroid Randomization After Significant Head Injury Trial Collaborators; Trauma Audit and Research Network. van Leeuwen N, et al. Among authors: roozenbeek b. Neurosurgery. 2012 Apr;70(4):811-8; discussion 818. doi: 10.1227/NEU.0b013e318235d640. Neurosurgery. 2012. PMID: 21904253
157 results